Get started

Financials · IRIX

IRIDEX Corporation (IRIX) financials

For the twelve months ended Jul 4, 2026, IRIDEX Corporation reported $51.57M of revenue and -$3.55M of net income.

Revenue, TTM
$51.57M
Revenue growth, YoY
+3.7%
Net income, TTM
-$3.55M
Net margin
-6.9%
Free cash flow, TTM
-$2.00M
EPS, diluted, TTM
-$0.20
Cash
$4.68M
Total debt
$3.79M
P/S
0.24
Market cap
$12.4M
Annual revenue$52.67M
FY2016FY2025
Annual net income-$4.44M
FY2016FY2025
Annual free cash flow-$2.26M
FY2016FY2025

IRIX revenue and earnings growth

IRIX revenueQ2 2026$12.57M

Quarter YoY
-7.4%
QoQ
+6.5%
FY YoY
+8.2%
5Y CAGR
+7.7%
10Y CAGR
+2.3%

IRIX revenue was $12.57M in fiscal Q2 2026 (ended Jul 4, 2026), down 7.4% from a year earlier and up 6.5% from the prior quarter. For the full fiscal 2025 it was $52.67M, up 8.2% from fiscal 2024. Compound annual growth was +7.7% over 5 years and +2.3% over 10 years. It rose in 6 of the last 10 fiscal years.

IRIX net incomeQ2 2026-$1.27M

IRIX net income was -$1.27M in fiscal Q2 2026 (ended Jul 4, 2026), compared with -$994.0K a year earlier. For the full fiscal 2025 it was -$4.44M, compared with -$8.91M in fiscal 2024.

IRIX EPSQ2 2026-$0.07

IRIX diluted EPS was -$0.07 in fiscal Q2 2026 (ended Jul 4, 2026), compared with -$0.06 a year earlier. For the full fiscal 2025 it was -$0.26, compared with -$0.54 in fiscal 2024.

IRIX free cash flowQ2 2026$124.0K

IRIX free cash flow was $124.0K in fiscal Q2 2026 (ended Jul 4, 2026), compared with -$410.0K a year earlier. For the full fiscal 2025 it was -$2.26M, compared with -$7.30M in fiscal 2024.

Export CSV

Income statement

Income statement
Line item
FY2025
Jan 3, 2026
FY2024
Dec 28, 2024
FY2023
Dec 30, 2023
FY2022
Dec 31, 2022
FY2021
Jan 1, 2022
FY2020
Jan 2, 2021
FY2019
Dec 28, 2019
FY2018
Dec 29, 2018
FY2017
Dec 30, 2017
FY2016
Dec 31, 2016
Revenue$52.67M$48.67M$51.87M$56.97M$53.90M$36.35M$43.45M$42.60M$41.59M$46.16M
Cost of revenue$33.45M$29.17M$30.06M$31.60M$31.07M$20.79M$25.51M$25.13M$26.09M$25.32M
Gross profit$19.23M$19.50M$21.81M$25.37M$22.83M$15.56M$17.94M$17.47M$15.50M$20.84M
Research and development$3.67M$5.45M$6.83M$7.17M$6.87M$3.28M$3.68M$4.01M$5.21M$5.37M
Selling, general and admin$7.73M$9.78M$8.75M$7.56M$8.86M$6.62M$8.38M$9.55M$8.78M$7.64M
Operating income-$2.57M-$8.30M-$10.01M-$7.54M-$7.53M-$6.58M-$8.97M-$12.87M-$12.89M-$2.56M
Pre-tax income-$4.38M-$8.84M-$9.48M-$7.48M-$5.18M-$6.30M-$8.77M-$12.78M-$12.99M-$2.66M
Income tax$57.0K$68.0K$90.0K$65.0K$40.0K$26.0K$48.0K$37.0K-$128.0K$9.06M
Net income-$4.44M-$8.91M-$9.57M-$7.55M-$5.22M-$6.33M-$8.81M-$12.81M-$12.87M-$11.71M
EPS, basic-$0.26-$0.54-$0.59-$0.47-$0.34-$0.46-$0.64-$1.05-$1.11-$1.15
EPS, diluted-$0.26-$0.54-$0.59-$0.47-$0.34-$0.46-$0.64-$1.05-$1.11-$1.15
Diluted shares16.9M16.4M16.1M15.9M15.4M13.8M13.7M12.2M11.6M10.2M

Balance sheet

Balance sheet
Line item
FY2025
Jan 3, 2026
FY2024
Dec 28, 2024
FY2023
Dec 30, 2023
FY2022
Dec 31, 2022
FY2021
Jan 1, 2022
FY2020
Jan 2, 2021
FY2019
Dec 28, 2019
FY2018
Dec 29, 2018
FY2017
Dec 30, 2017
FY2016
Dec 31, 2016
Cash and equivalents$6.03M$2.39M$7.03M$13.92M$23.85M$11.63M$12.65M$21.19M$21.71M$23.75M
Receivables$7.61M$5.95M$6.73M$6.23M$6.61M$7.29M$9.32M$9.08M$7.86M$10.03M
Inventory$7.88M$10.82M$9.91M$10.61M$7.61M$5.71M$8.17M$8.79M$9.38M$11.64M
Current assets$25.25M$23.56M$27.45M$35.77M$42.25M$25.36M$30.55M$39.62M$39.45M$45.87M
Goodwill$965.0K$965.0K$965.0K$965.0K$965.0K$533.0K$533.0K$533.0K$533.0K$533.0K
Total assets$29.15M$29.14M$34.44M$42.29M$48.69M$27.97M$34.81M$41.67M$41.65M$48.14M
Current liabilities$13.21M$16.56M$12.97M$12.45M$12.65M$8.68M$9.78M$10.50M$10.39M$8.17M
Short-term debt-$1.70M---$1.25M----
Long-term debt$3.73M$1.00M$0-------
Total debt$3.73M$2.70M$0--$1.25M----
Total liabilities$24.23M$27.04M$24.91M$25.06M$25.39M$10.60M$12.11M$11.71M$11.12M$8.98M
Shareholders' equity$4.92M$2.10M$9.52M$17.23M$23.30M$17.37M$22.70M$29.96M$30.52M$39.16M

Cash flow

Cash flow
Line item
FY2025
Jan 3, 2026
FY2024
Dec 28, 2024
FY2023
Dec 30, 2023
FY2022
Dec 31, 2022
FY2021
Jan 1, 2022
FY2020
Jan 2, 2021
FY2019
Dec 28, 2019
FY2018
Dec 29, 2018
FY2017
Dec 30, 2017
FY2016
Dec 31, 2016
Operating cash flow-$2.12M-$7.29M-$6.75M-$9.52M$8.22M-$3.24M-$7.91M-$10.03M-$3.56M-$144.0K
Capital expenditures$143.0K$13.0K$109.0K$286.0K$213.0K$97.0K$128.0K$440.0K$575.0K$1.06M
Free cash flow-$2.26M-$7.30M-$6.85M-$9.80M$8.00M-$3.33M-$8.04M-$10.46M-$4.14M-$1.21M
Investing cash flow-$143.0K-$13.0K-$109.0K-$286.0K-$5.56M-$93.0K-$509.0K-$827.0K-$782.0K-$1.47M
Financing cash flow$5.96M$2.60M-$5.0K-$73.0K$9.47M$2.47M-$156.0K$10.38M$2.31M$15.36M
Share repurchases---------$59.0K
Depreciation and amortization$523.0K$584.0K$1.10M$485.0K$803.0K$504.0K$688.0K$809.0K$858.0K$648.0K

Key ratios

Key ratios
Line item
FY2025
Jan 3, 2026
FY2024
Dec 28, 2024
FY2023
Dec 30, 2023
FY2022
Dec 31, 2022
FY2021
Jan 1, 2022
FY2020
Jan 2, 2021
FY2019
Dec 28, 2019
FY2018
Dec 29, 2018
FY2017
Dec 30, 2017
FY2016
Dec 31, 2016
Revenue growth, YoY8.2%-6.2%-9.0%5.7%48.3%-16.3%2.0%2.4%-9.9%10.5%
Gross margin36.5%40.1%42.0%44.5%42.4%42.8%41.3%41.0%37.3%45.1%
Operating margin-4.9%-17.1%-19.3%-13.2%-14.0%-18.1%-20.7%-30.2%-31.0%-5.6%
Net margin-8.4%-18.3%-18.5%-13.2%-9.7%-17.4%-20.3%-30.1%-30.9%-25.4%
Free cash flow margin-4.3%-15.0%-13.2%-17.2%14.8%-9.2%-18.5%-24.6%-10.0%-2.6%
Return on equity-90.1%-424.9%-100.5%-43.8%-22.4%-36.4%-38.8%-42.8%-42.2%-29.9%
Return on assets-15.2%-30.6%-27.8%-17.8%-10.7%-22.6%-25.3%-30.7%-30.9%-24.3%
Current ratio1.911.422.122.873.342.923.123.773.805.62
Debt to equity0.761.290.00--0.07----

Source: XBRL data IRIDEX Corporation files with the SEC, latest filing dated Aug 18, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

IRIX peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
IRIX$51.57M+3.7%-$3.55M-6.9%$12.4M
MDT$37.54B+9.8%$5.24B14.0%$131.48B
LIVN$1.51B+11.7%$196.06M13.0%$5.10B
ITGR$1.83B-0.3%$103.70M5.7%$4.30B
TMDX$727.65M+28.5%$144.45M19.9%$3.26B
AXGN$266.93M+24.3%-$31.92M-12.0%$3.02B
CNMD$1.37B+1.6%$73.43M5.4%$1.55B
CBLL$108.72M+31.3%-$73.88M-68.0%$1.07B
INMD$370.50M-6.2%$93.83M25.3%$776.6M

IRIX FAQ

9 questions
  • What is IRIX revenue?
    IRIDEX Corporation (IRIX) reported $51.57M of revenue for the twelve months ended Jul 4, 2026. That is up 3.7% from the year before. Revenue for fiscal 2025 was $52.67M.
  • Is IRIX profitable?
    No. IRIDEX Corporation reported a net loss of $3.55M for the twelve months ended Jul 4, 2026.
  • How much cash and debt does IRIX have?
    IRIDEX Corporation reported $4.68M in cash and cash equivalents and $3.79M of debt on its most recent balance sheet in SEC filings.
  • How fast is IRIX revenue growing?
    IRIDEX Corporation's revenue changed +8.2% in fiscal 2025, to $52.67M. Its compound annual growth rate was +7.7% over 5 years and +2.3% over 10 years.
  • What is IRIX gross margin?
    IRIDEX Corporation's gross profit was $18.53M on $51.57M of revenue for the twelve months ended Jul 4, 2026, a gross margin of 35.9%.
  • What is IRIX free cash flow?
    IRIDEX Corporation generated -$2.00M of free cash flow for the twelve months ended Jul 4, 2026, which is operating cash flow of -$1.73M less capital expenditures.
  • What is IRIX earnings per share?
    Diluted earnings per share were -$0.20 for the twelve months ended Jul 4, 2026, from SEC filings, restated for any stock split those filings show.
  • When did IRIX last report financial results?
    The latest statements here come from IRIDEX Corporation's 10-Q filed on Aug 18, 2026, covering the period ended Jul 4, 2026.
  • Where does this IRIX financial data come from?
    Quantisnow builds these statements from the structured XBRL data IRIDEX Corporation files with the SEC. It is provided for information only and is not investment advice.